| 1 | Dexmedetomidine | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 00212件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 | 
| 2 | Dexmedetomidine 1 | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 2801件: 280 💬 | 
| 3 | Dexmedetomidine 2 | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 2801件: 280 💬 | 
| 4 | Dexmedetomidine 3 | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 2801件: 280 💬 | 
| 5 | Dexmedetomidine group | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 0701件: 70 💬 | 
| 6 | Dexmedetomidine hydrochloride | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 0701件: 70 💬 | 
| 7 | Dexmedetomidine hydrochloride infusion | Dexmedetomidine | 2件: D00514D00514, D01205D01205 💬 | ADRA2A3件: ADRA2A, ADRA2B, ADRA2C 💬 | Neuroactive ligand-receptor interaction2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 8 | Dexmedetomidine with ropivacaine | Dexmedetomidine | 4件: D00514D00514, D01205D01205, D04048D04048, D08490D08490 💬 | ADRA2A8件: ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | Adrenergic signaling in cardiomyocytes5件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway | 0701件: 70 💬 | 
| 9 | Fentanyl (low dose) + dexmedetomidine | Dexmedetomidine | 4件: D00320D00320, D00514D00514, D01205D01205, D01399D01399 💬 | ADRA2A4件: ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 | Estrogen signaling pathway4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway | 2151件: 215 💬 | 
| 10 | Scopolamine, atropine, edaravone and dexmedetomidine | Atropine | 9件: D00113D00113, D00138D00138, D00514D00514, D01077D01077, D01205D01205, D01552D01552, D02069D02069, D03011D03011, D03814D03814 💬 | ADRA2A8件: ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | Alzheimer disease14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway | 0021件:  2  💬 |